IKT
Price
$1.56
Change
-$0.02 (-1.27%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
191.6M
Intraday BUY SELL Signals
SNDX
Price
$20.43
Change
-$0.83 (-3.91%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
1.85B
33 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IKT vs SNDX

Header iconIKT vs SNDX Comparison
Open Charts IKT vs SNDXBanner chart's image
Inhibikase Therapeutics
Price$1.56
Change-$0.02 (-1.27%)
Volume$6.4K
Capitalization191.6M
Syndax Pharmaceuticals
Price$20.43
Change-$0.83 (-3.91%)
Volume$9.36K
Capitalization1.85B
IKT vs SNDX Comparison Chart in %
IKT
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IKT vs. SNDX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IKT is a Hold and SNDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (IKT: $1.58 vs. SNDX: $21.25)
Brand notoriety: IKT and SNDX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IKT: 106% vs. SNDX: 58%
Market capitalization -- IKT: $191.6M vs. SNDX: $1.85B
IKT [@Biotechnology] is valued at $191.6M. SNDX’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IKT’s FA Score shows that 0 FA rating(s) are green whileSNDX’s FA Score has 1 green FA rating(s).

  • IKT’s FA Score: 0 green, 5 red.
  • SNDX’s FA Score: 1 green, 4 red.
According to our system of comparison, both IKT and SNDX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IKT’s TA Score shows that 3 TA indicator(s) are bullish while SNDX’s TA Score has 3 bullish TA indicator(s).

  • IKT’s TA Score: 3 bullish, 7 bearish.
  • SNDX’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, SNDX is a better buy in the short-term than IKT.

Price Growth

IKT (@Biotechnology) experienced а -6.51% price change this week, while SNDX (@Biotechnology) price change was -0.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

SNDX is expected to report earnings on Mar 09, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNDX($1.85B) has a higher market cap than IKT($192M). SNDX YTD gains are higher at: 1.142 vs. IKT (-22.927). IKT has higher annual earnings (EBITDA): -53.08M vs. SNDX (-282.58M). SNDX has more cash in the bank: 454M vs. IKT (77.3M). IKT has less debt than SNDX: IKT (0) vs SNDX (1.52M). SNDX has higher revenues than IKT: SNDX (111M) vs IKT (0).
IKTSNDXIKT / SNDX
Capitalization192M1.85B10%
EBITDA-53.08M-282.58M19%
Gain YTD-22.9271.142-2,007%
P/E Ratio3.36N/A-
Revenue0111M-
Total Cash77.3M454M17%
Total Debt01.52M-
FUNDAMENTALS RATINGS
SNDX: Fundamental Ratings
SNDX
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
5
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IKTSNDX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 14 days ago
82%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 8 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
IKT
Daily Signal:
Gain/Loss:
SNDX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNRZX86.963.41
+4.08%
PGIM Jennison Natural Resources Z
MLPLX6.440.13
+2.06%
Invesco SteelPath MLP Alpha Plus A
URITX33.310.13
+0.39%
Victory International R6
WFPAX46.620.09
+0.19%
Allspring Special Mid Cap Value A
HSUAX38.40-0.89
-2.27%
Rational Dynamic Brands A

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with SYRE. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+0.64%
SYRE - IKT
33%
Loosely correlated
+1.65%
ZNTL - IKT
31%
Poorly correlated
+12.35%
SNDX - IKT
31%
Poorly correlated
-0.47%
VIR - IKT
30%
Poorly correlated
-0.39%
CGON - IKT
30%
Poorly correlated
-3.28%
More

SNDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SNDX has been loosely correlated with REPL. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if SNDX jumps, then REPL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNDX
1D Price
Change %
SNDX100%
-0.47%
REPL - SNDX
51%
Loosely correlated
+5.81%
CGON - SNDX
48%
Loosely correlated
-3.28%
ACLX - SNDX
47%
Loosely correlated
-0.01%
NUVL - SNDX
47%
Loosely correlated
+2.12%
IDYA - SNDX
46%
Loosely correlated
+0.50%
More